SURROGEN
Surrogen is a biotech company delivering better models to understand human disease. It accelerates biomedical innovation by providing the drug and medical device industries with genetically-engineered, tailored large animal models as precise, reliable platforms to accelerate medical device and pharmaceutical development. The company's Patient Models help improve, enhance, and extend human life by providing large animal disease models that faithfully reproduce the disease indications seen in hum... an patients. Leveraging the critical assumption that the best substitutes are those closest to the original, Surrogen’s Patient Models bridge the gap between traditional animal models and clinical studies and serve as a platform to prove or disprove new ideas, exponentially speed up discovers, and significantly lower the total cost of getting new medical devices and drugs tested, approved and into use. Surrogen utilizes game-changing genetic technologies to develop large animal models with specific maladies and genetic conditions that provide a groundbreaking, preclinical opportunity for the world’s leading researchers, medical device, and pharmaceutical innovators to diminish lead times, lower research costs and reduce failure rates.
SURROGEN
Social Links:
Industry:
Biotechnology Genetics Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Eagan, Minnesota, United States
Country:
United States
Website Url:
http://www.recombinetics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
ASIP
ASIP is a society of biomedical scientists who investigate mechanisms of disease.
biOOrg3.14
biOOrg3.14 develops technologies and small molecules to fight human disease.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
NeuClone
NeuClone is a biotechnology company developing and commercializing high quality biosimilars.
Regenevida
Regenevida is a biotech company developing transplantable cells, tissues, and organs to save lives.
Warren Center for Neuroscience Drug Discovery
Warren Center for Neuroscience Drug Discovery is a traditional academy in basic science to understand and treat human disease.
Official Site Inspections
http://www.recombinetics.com
- Host name: 202.88.225.35.bc.googleusercontent.com
- IP address: 35.225.88.202
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York

More informations about "Surrogen"
Our Company - Recombinetics
Recombinetics’ ever-expanding pipeline of gene-edited animals, products, and preclinical services, position the company for rapid growth in biomedical and …See details»
Recombinetics - Crunchbase Company Profile & Funding
Recombinetics is a developer of gene editing technologies to improve human health through advanced disease models and regenerative medicine. Its gene-editing technologies …See details»
Our Team - Recombinetics
Recombinetics has strategically built our organization around two core markets— preclinical research & services, and a safe, abundant food supply. Our …See details»
Recombinetics - Wikipedia
Recombinetics is a St. Paul, Minnesota-based bio-engineering company. [1] The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the …See details»
Recombinetics - LinkedIn
Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing …See details»
Recombinetics 2025 Company Profile: Valuation, Funding
When was Recombinetics founded? Recombinetics was founded in 2008. Where is Recombinetics headquartered? Recombinetics is headquartered in Eagan, MN. What is the …See details»
Recombinetics Company Profile | Management and Employees List …
Recombinetics Profile and History. Founded in 2008, Recombinetics Inc. is a recognized global leader in the development, deployment, and commercialization of genetically engineered large …See details»
Recombinetics - Funding, Financials, Valuation & Investors
Aug 23, 2020 Recombinetics is funded by Grant Newlin. Recombinetics has a post-money valuation in the range of $100M to $500M as of Aug 22, 2018, according to PrivCo. Sign up for …See details»
Recombinetics - Company Profile - Tracxn
Feb 7, 2025 Recombinetics - Develops gene repair and gene-editing technology to create animal models. Raised a total funding of $65.5M over 12 rounds from 3 investors. Founded by Perry …See details»
Recombinetics Inc - Company Profile and News - Bloomberg …
Company profile page for Recombinetics Inc including stock price, company news, executives, board members, and contact informationSee details»
Company: Recombinetics
Mar 12, 2025 Recombinetics is gene-editing company, mainly focused on genetically engineering animals for agricultural and biomedical applications. The company's biomedical …See details»
Recombinetics | VentureRadar
Recombinetics develops and utilizes the best of gene editing technology to improve and lengthen human lives, and to improve and grow agriculture to help feed the world’s growing population …See details»
Recombinetics Company Information - Funding, Investors, and More
Recombinetics is a biotechnology company that uses gene editing for agriculture and medicine . Seedtable Score 76 Startups. 11. Funding Rounds. $67.4m. Money raised. About; Insights; …See details»
Recombinetics - Products, Competitors, Financials, Employees ...
Recombinetics focuses on animal gene editing and applied technologies in biomedical research, regenerative medicine, and animal agriculture. The company has a gene editing platform that …See details»
Recombinetics Company Overview, Contact Details & Competitors …
Gene-editing Technology Leader Recombinetics is a global leader in gene-editing technology, offering breakthrough solutions for regenerative medicine, disease research, and animal …See details»
Our Technology - Recombinetics
Recombinetics deploys gene editing in agriculture and aquaculture through its subsidiary Acceligen. Acceligen is the world leader in what is often referred to as “precision breeding”, …See details»
Recombinetics Company Profile - Craft
Recombinetics has 5 employees at their 1 location and $60.95 m in total funding,. See insights on Recombinetics including office locations, competitors, revenue, financials, executives, …See details»
Recombinetics Announces New Chief Executive Officer
Feb 11, 2019 PAUL, Minn.--(BUSINESS WIRE)--Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today named Mark Platt the organization’s …See details»
Recombinetics Chapter 11 - Recombinetics
On November 11, 2024, Recombinetics, Inc. (“Recombinetics” or “the Company”) announced a restructuring process intended to pave the way for a sale of substantially all of the Company’s …See details»